This work is licensed under the Creative Commons Attribution 4.0 International License.
Nooreldeen R, Bach H. Current and Future Development in Lung Cancer Diagnosis. Int J Molec Sci. 2021;22(16):10. DOI: 10.3390/ijms22168661Search in Google Scholar
Ganti AK, Klein AB, Cotarla I, Seal B, Chou E. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US. JAMA oncol. 2021;7(12):1824-32. DOI: 10.1001/jamaoncol.2021.4932Search in Google Scholar
Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet (London, England). 2016;388(10055):2023-38. DOI: 10.1016/S0140-6736(16)30173-8Search in Google Scholar
Lin YJ, Anzaghe M, Schülke S. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells. 2020;9(4):10. DOI: 10.3390/cells9040880Search in Google Scholar
Venetsanopoulou AI, Alamanos Y, Voulgari PV, Drosos AA. Epidemiology of rheumatoid arthritis: genetic and environmental influences. Expert rev clin immunol. 2022;18(9):923-31. DOI: 10.1080/1744666X.2022.2106970Search in Google Scholar
Rubbert-Roth A, Zander T, Kneitz C, Baerwald C, Wirtz H, Witt C. [Lung cancer and rheumatoid arthritis. An interdisciplinary challenge]. Zeitschrift fur Rheumatologie. 2016;75(1):47-53. DOI: 10.1007/s00393-016-0043-0Search in Google Scholar
Wu X, Peng H, Wen Y, Cai X, Li C, Zhong R, et al. Rheumatoid arthritis and risk of lung cancer: Meta-analysis and Mendelian randomization study. Sem arthr rheum. 2021;51(3):565-75. DOI: 10.1016/j.semarthrit.2021.03.015Search in Google Scholar
Fragoulis GE, Chatzidionysiou K. Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening? Clin rheum. 2020;39(3):957-61. DOI: 10.1007/s10067-019-04882-xSearch in Google Scholar
Zhao W, Langfelder P, Fuller T, Dong J, Li A, Hovarth S. Weighted gene coexpression network analysis: state of the art. J Biopharm stat. 2010;20(2):281-300. DOI: 10.1080/10543400903572753Search in Google Scholar
Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC bioinformatics. 2008;9:559. DOI: 10.1186/1471-2105-9-559Search in Google Scholar
Rhoads A, Au KF. PacBio Sequencing and Its Applications. Genomics, proteomics & bioinformatics. 2015;13(5):278-89. DOI: 10.1016/j.gpb.2015.08.002Search in Google Scholar
Zhang J, Li Y, Yang Y, Huang J, Sun Y, Zhang X, et al. A novel iTreg-related signature for prognostic prediction in lung adenocarcinoma. Cancer sci. 2023. DOI: 10.1111/cas.16015Search in Google Scholar
Viktorsson K, Hååg P, Shah CH, Franzén B, Arapi V, Holmsten K, et al. Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome. Molec oncol. 2022;16(20):3620-41. DOI: 10.1002/1878-0261.13288Search in Google Scholar
Liu Y, Fan S, Meng S. Identification of the candidate genes of diagnosing rheumatoid arthritis using the single-cell sequencing technology and T cell subclusters analysis of patients with rheumatoid arthritis. Archiv rheumatol. 2023;38(1):109-18. DOI: 10.46497/ArchRheumatol.2022.9573Search in Google Scholar
Zhu N, Yang Y, Wang H, Tang P, Zhang H, Sun H, et al. CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma. Front Oncol. 2022;12:822849. DOI: 10.3389/fonc.2022.822849Search in Google Scholar
Fan C, Hu H, Shen Y, Wang Q, Mao Y, Ye B, et al. PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma. Translational oncol. 2021;14(4):101042. DOI: 10.1016/j.tranon.2021.101042Search in Google Scholar
Zhao Z, Ren J, Xie S, Zou L, Zhao Q, Zeng S, et al. Identification of biomarkers associated with CD8+ T cells in rheumatoid arthritis and their pan-cancer analysis. Front immunol. 2022;13:1044909. DOI: 10.3389/fimmu.2022.1044909Search in Google Scholar
Mukherjee A, Epperly MW, Fisher R, Hou W, Shields D, Saiful Huq M, et al. Inhibition of tyrosine kinase Fgr prevents radiation-induced pulmonary fibrosis (RIPF). Cell death discovery. 2023;9(1):252. DOI: 10.1038/s41420-023-01538-3Search in Google Scholar
Lu T, Xu R, Wang C, Zhou X, Parra-Medina R, Díaz-Peña R, et al. Bioinformatics analysis and single-cell RNA sequencing: elucidating the ubiquitination pathways and key enzymes in lung adenocarcinoma. J thoracic disease. 2023;15(7):3885-907. DOI: 10.21037/jtd-23-795Search in Google Scholar
Schioppa T, Sozio F, Barbazza I, Scutera S, Bosisio D, Sozzani S, et al. Molecular Basis for CCRL2 Regulation of Leukocyte Migration. Front cell develop biol. 2020;8:615031. DOI: 10.3389/fcell.2020.615031Search in Google Scholar
Del Prete A, Sozio F, Schioppa T, Ponzetta A, Vermi W, Calza S, et al. The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance. Cancer immunol res. 2019;7(11):1775-88. DOI: 10.1158/2326-6066.CIR-19-0168Search in Google Scholar
Sozio F, Schioppa T, Laffranchi M, Salvi V, Tamassia N, Bianchetto-Aguilera FM, et al. CCRL2 Expression by Specialized Lung Capillary Endothelial Cells Controls NK-cell Homing in Lung Cancer. Cancer immunol res. 2023;11(9):1280-95. DOI: 10.1158/2326-6066.CIR-22-0951Search in Google Scholar
Hamed KM, Dighriri IM, Baomar AF, Alharthy BT, Alenazi FE, Alali GH, et al. Overview of Methotrexate Toxicity: A Comprehensive Literature Review. Cureus. 2022;14(9):e29518. DOI: 10.7759/cureus.29518Search in Google Scholar
Wang W, Zhou H, Liu L. Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review. Eur J med chem. 2018;158:502-16. DOI: 10.1016/j.ejmech.2018.09.027Search in Google Scholar
Xie M, Chen X, Qin S, Bao Y, Bu K, Lu Y. Clinical study on thalidomide combined with cinobufagin to treat lung cancer cachexia. J cancer res therap. 2018;14(1):226-32. DOI: 10.4103/0973-1482.188436Search in Google Scholar
Dsouza NN, Alampady V, Baby K, Maity S, Byregowda BH, Nayak Y. Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis. Inflammopharmacology. 2023;31(3):1167-82. DOI: 10.1007/s10787-023-01193-1Search in Google Scholar